Thanks for your thoughts on this. This is why I believe they went for additional indications, as they weren't quite ready on this yet, and needed to spend more time. So, why not add in additional indications for FDA approval at the same time? Its pennys on the dollar relative to what they're spending on fine tuning. JMHO, and for this reason it's why I think their timelines are padded..
News 
Market Data 
Discover 
AI
